Aurora Cannabis Inc (NYSE:ACB) gapped up prior to trading on Tuesday . The stock had previously closed at $8.05, but opened at $7.94. Aurora Cannabis shares last traded at $7.78, with a volume of 7717044 shares.
A number of equities research analysts have issued reports on the stock. Stifel Nicolaus assumed coverage on shares of Aurora Cannabis in a research report on Wednesday, June 5th. They issued a “hold” rating for the company. Zacks Investment Research upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Monday, May 20th. Desjardins assumed coverage on shares of Aurora Cannabis in a research report on Thursday, April 25th. They issued a “buy” rating and a $9.07 target price for the company. Bank of America assumed coverage on shares of Aurora Cannabis in a research report on Wednesday, April 17th. They issued a “buy” rating and a $11.00 target price for the company. Finally, TheStreet upgraded shares of Aurora Cannabis from a “d+” rating to a “c” rating in a research report on Thursday, April 4th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Aurora Cannabis has a consensus rating of “Buy” and an average target price of $9.86.
The company has a market capitalization of $7.89 billion, a P/E ratio of 64.58 and a beta of 2.80. The company has a current ratio of 2.37, a quick ratio of 1.98 and a debt-to-equity ratio of 0.10.
COPYRIGHT VIOLATION WARNING: “Aurora Cannabis (NYSE:ACB) Shares Gap Up to $7.94” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/4370258/aurora-cannabis-nyseacb-shares-gap-up-to-7-94.html.
Aurora Cannabis Company Profile (NYSE:ACB)
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Featured Article: Outstanding Shares, Buying and Selling Stocks
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.